Literature DB >> 32579073

Zika virus envelope - heat shock protein A5 (GRP78) binding site prediction.

Abdo A Elfiky1, Ibrahim M Ibrahim1.   

Abstract

Recent studies reported the association of the Zika virus (ZIKV) with a stress response receptor on the host cell membrane that facilitates viral entry. This host receptor was the heat shock protein A5 (HSPA5), also termed glucose-regulating protein 78 (GRP78). In this study, structural bioinformatics and molecular dynamics simulations were utilized to suggest the binding site of ZIKV envelope protein during the interaction with cell-surface GRP78. The Pep42 cyclic peptide was used as a profiler, as it was reported earlier, to target GRP78 on the cancer cell membrane selectively. Sequence and structural alignments show that part of the ZIKV envelope protein (C308-C339 region), in addition to its cyclic nature, has somehow sequence and structural similarities to the cyclic Pep42. Three amino acids in the ZIKV envelope were identical to those in the Pep42 peptide. Cyclic peptides dynamics are studied, and its binding to GRP78 is predicted. Protein-protein docking is further performed to explore the binding characteristics of the ZIKV envelope to GRP78. Results revealed that the binding was favorable between ZIKV envelope protein and GRP78. The docking pose revealed the involvement of the substrate-binding domain ß of GRP78 and the domain III of the ZIKV envelope protein in viral recognition for the host-cell.

Entities:  

Keywords:  BiP; GRP78; Pep42; ZIKV envelope; protein-protein docking; structural bioinformatics

Mesh:

Substances:

Year:  2020        PMID: 32579073     DOI: 10.1080/07391102.2020.1784794

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  8 in total

1.  Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.

Authors:  Hany M Dabbous; Sherief Abd-Elsalam; Manal H El-Sayed; Ahmed F Sherief; Fatma F S Ebeid; Mohamed Samir Abd El Ghafar; Shaimaa Soliman; Mohamed Elbahnasawy; Rehab Badawi; Mohamed Awad Tageldin
Journal:  Arch Virol       Date:  2021-01-25       Impact factor: 2.574

2.  Host cytoskeletal vimentin serves as a structural organizer and an RNA-binding protein regulator to facilitate Zika viral replication.

Authors:  Yue Zhang; Shuangshuang Zhao; Yian Li; Fengping Feng; Min Li; Yanhong Xue; Jie Cui; Tao Xu; Xia Jin; Yaming Jiu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-22       Impact factor: 12.779

3.  Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective.

Authors:  Sphamandla E Mtambo; Samuel C Ugbaja; Hezekiel M Kumalo
Journal:  Molecules       Date:  2022-03-02       Impact factor: 4.411

4.  SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective.

Authors:  Abdo A Elfiky; Ibrahim M Ibrahim; Alaa M Elgohary
Journal:  Int J Pept Res Ther       Date:  2022-08-22       Impact factor: 2.191

5.  A Redox-Probe-Free Immunosensor Based on Electrocatalytic Prussian Blue Nanostructured Film One-Step-Prepared for Zika Virus Diagnosis.

Authors:  Lorenna K B Santos; Priscila D Mendonça; LiLian K S Assis; Carlos R Prudêncio; Maria Izabel F Guedes; Ernesto T A Marques; Rosa Fireman Dutra
Journal:  Biosensors (Basel)       Date:  2022-08-10

6.  Is There any Alternative Receptor for SARS-CoV-2?

Authors:  Mahtab Shahriari Felordi; Arash Memarnejadian; Mustapha Najimi; Massoud Vosough
Journal:  Cell J       Date:  2021-05-26       Impact factor: 2.479

7.  Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.

Authors:  Amr Sonousi; Hanan A Mahran; Ibrahim M Ibrahim; Mohamed N Ibrahim; Abdo A Elfiky; Wael M Elshemey
Journal:  Pharmacol Rep       Date:  2021-06-24       Impact factor: 3.919

Review 8.  Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2.

Authors:  F Carrouel; L S Gonçalves; M P Conte; G Campus; J Fisher; L Fraticelli; E Gadea-Deschamps; L Ottolenghi; D Bourgeois
Journal:  J Dent Res       Date:  2020-10-22       Impact factor: 6.116

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.